Trial NCT04283461; NCT04785144
Publication Anderson E, SSRN, 2022
Dates: 2021-03-29 to 2021-04-30
Funding: Mixed (Infectious Diseases Clinical Research Consortium through the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, under award number UM1AI148684, and by award numbers UM1AI148373 (Kaiser Washington), UM1AI148576 (Emory University), and HHSN272201500002C (Emmes). Moderna, Inc. provided mRNA-1273 and mRNA-1273.351 for the booster vaccinations and some authors are Moderna employees.)
Conflict of interest: Yes